Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Clinical trial NCT00003407 · WITHDRAWN

Trial details

NCT number: NCT00003407
Sponsor: Rush University Medical Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Leukemia Myelodysplastic Syndromes Neutropenia

Start date: 2001-02-13
Primary completion: 2004-04-07
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.